Literature DB >> 2676406

Treatment of various infections in an outpatient practice by intramuscular ceftriaxone: home parenteral therapy.

G N Karachalios1, A N Georgiopoulos, S Kanatakis.   

Abstract

Ceftriaxone, a broad-spectrum third-generation cephalosporin with a long half-life, was administered intramuscularly to 23 outpatients who had a variety of infectious diseases. Cure was achieved in 21 of the patients (91%). The results of this study indicate that ceftriaxone is an effective and well-tolerated antimicrobial agent when administered intramuscularly to outpatients with various infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676406     DOI: 10.1159/000238700

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

1.  Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.

Authors:  R Davis; H M Bryson
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

2.  Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections.

Authors:  S Segev; R Raz; E Rubinstein; H Shmuely; D Hassin; N Rosen; E Platau; S Ben Assuli; S Pitlik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

Review 3.  Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.

Authors:  D Nathwani
Journal:  Drugs       Date:  2000       Impact factor: 9.546

4.  Outpatient parenteral antibiotic therapy (OPAT) at home in Attica, Greece.

Authors:  G Theocharis; P I Rafailidis; D Rodis; I Kontopidis; S G Barbas; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-02       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.